The star said that the drug left her feeling nauseous and added that it also left another friend feeling similarly sick
Bearish Takeaways Mizuho also flags concentration risk, noting that the investment case is still tightly linked to the weight loss management program, which could leave the story sensitive to any changes in GLP-1 adoption or competitive dynamics
GLP-1 medications can help manage type 2 diabetes and obesity, but they may cause short-term mild-to-moderate side effects such as nausea, vomiting, diarrhoea, constipation, bloating, and decreased appetite, particularly at the beginning of treatment
"At the start of this year, a new 7.2mg dose was approved, with people losing an average of 18.7 per cent of their starting body weight." However, the Wegovy pill is the first of multiple GLP-1 pills which are likely to hit the market over the next few years